glutathion synthese glutathione biosynthesis Glutathione in Protein Redox Modulation

In contrast, the A30P transgenic mouse model exhibits non-motor symptom disorders characteristic of early-stage PD in humans (Veys et al., 2021)

Biomed Pharmacother 178:117174 Ma W, Hu J, Cheng Y, Wang J, Zhang X, Xu M (2015) Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of AktNrf2HO-1 signaling and reduction of NADPH oxidase

The findings highlight the significant impact of genetic variation on refining hepatic steatosis prediction

50 & Target IC50: 8.9 nM (rat uterus oxytocin receptor), 26 nM (human uterus oxytocin receptor) [1] In Vitro L-368,899 hydrochloride is a potent, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC 50 s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively